« Previous article
Thermo Fisher's ...

27th August 2020  Content supplied by: Thermo Fisher Scientific (Clinical Applications)

Seasonal Flu and Coronavirus Identification


Both coronavirus and influenza (flu) can affect people to varying degrees, ranging from no symptoms (asymptomatic) to severe symptoms.

There are two main types of influenza virus: Types A and B. The influenza A and B viruses that routinely spread in people are responsible for seasonal flu epidemics each year. Influenza viruses infect the nose, throat, and sometimes the lungs, causing mild to severe illness, and at times can lead to death.

The CDC estimates that influenza was associated with more than 35.5 million illnesses, more than 16.5 million medical visits, 490,600 hospitalizations, and 34,200 deaths during the 2018–2019 influenza season1. The World Health Organization estimates that worldwide, annual influenza epidemics result in about 3-5 million cases of severe illness and about 250,000 to 500,000 deaths2.

The European Centre for Disease Prevention and Control provide a coronavirus situation update worldwide. Since 31 December 2019 and as of 20 August 2020, 22,431,929 cases of coronavirus (in accordance with the applied case definitions and testing strategies in the affected countries) have been reported, including 787,773 deaths3.

Patients with respiratory infections including flu may present symptoms similar to those associated with coronavirus, making fast and accurate pathogen identification more difficult.

Xpect_Flu_002resize

When it comes to Flu A and Flu B testing Thermo Scientific Xpect Flu A&B allows physicians to make a rapid diagnosis with confidence, which is essential for reducing secondary testing, decreasing unnecessary antibiotic use, and guiding appropriate antiviral therapy.

Introducing the Thermo Scientific™ Xpect™ Flu A&B Kits promotion which is available NOW until October 30, 2020*.

Buy 4 Xpect Flu A&B Kits and received 1 extra at no additional charge! Application form 

*Terms and conditions.
Offer valid August 17, 2020 through October 30, 2020 for U.S. customers only. You must submit an Xpect Flu A&B Test Kit purchase order along with the promotional form in order to receive the kits at no additional charge. Offer limited to one promotional form submission per customer. No limit on kit order quantity. Purchase orders and promotional forms must be received by November 30, 2020 to receive the kit(s) at no additional charge. We reserve the right to discontinue this promotion for any reason and without prior advance notice. Please note that the value of the kit(s) that the customer may receive from the manufacturer under this offer is a “discount or other reduction in price” to the customer under section 1128B(b)(3)(A) of the Social Security Act [42 U.S.C. 1320a-7b(b)(3)(a)]. Accordingly, the customer shall disclose this and any other discounts or other reduction in price received under this offer under any state or federal program as required by applicable law.

References

1. Estimated Influenza Illnesses, Medical visits, Hospitalizations, and Deaths in the United States — 2018–2019 influenza season. Centres for Disease Control and Prevention

2. World Health Organization

3. European Centre for Disease Prevention and Control COVID-19 situation update worldwide, as of 20 August 2020

3. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Lancet. 2020 Mar 11[Online ahead of print].

 


    

Tags:

Date Published: 27th August 2020

Source article link: View


View full company details


« Previous article
Thermo Fisher's US Contract